LTRN (Lantern Pharma) Institutional Ownership: 16.51% (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTRN Lantern Pharma Inc LTRN
34 GF Score
Price $2.76
! 2 Warning Signs
View Full Analysis

What is Lantern Pharma Institutional Ownership?

Lantern Pharma LTRN +5.36% 34 Institutional Ownership is 16.51% as of Aug. 04, 2026. GuruFocus rates LTRN with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lantern Pharma's institutional ownership is 16.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lantern Pharma's Insider Ownership is 4.58%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lantern Pharma's Float Percentage Of Total Shares Outstanding is 99.63%.

Lantern Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Lantern Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantern Pharma Institutional Ownership Chart

Lantern Pharma Historical Data

The historical data trend for Lantern Pharma can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 7.28 7.17 6.38 6.40 6.39 6.55 6.43 5.81 6.41 6.40
LTRN
34GF Score
Lantern Pharma Inc LTRN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lantern Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 16.51% mean?
Lantern Pharma (LTRN) has a Institutional Ownership of 16.51% as of Aug. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Lantern Pharma and its competitors.
Is Lantern Pharma's Institutional Ownership too high?
Lantern Pharma's current Institutional Ownership is 16.51%. Overall, Lantern Pharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Lantern Pharma's Institutional Ownership compare to VERU and NTRB?
Lantern Pharma's Institutional Ownership of 16.51% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Lantern Pharma and its competitors. Lantern Pharma's current Institutional Ownership is 16.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantern Pharma stock overvalued right now?
Lantern Pharma (LTRN) has a current Institutional Ownership of 16.51%. The current Institutional Ownership is 16.51%. Lantern Pharma's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Lantern Pharma (LTRN), the current Institutional Ownership is 16.51% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lantern Pharma Business Description

Address 1920 McKinney Avenue, 7th Floor, Dallas, TX, USA, 75201
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
34GF Score

Get the complete analysis for LTRN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.76
Price